Global Therapeutic Monoclonal Antibodies Drug Supply, Demand and Key Producers, 2023-2029
The global Therapeutic Monoclonal Antibodies Drug market size is expected to reach $ 336740 million by 2029, rising at a market growth of 10.5% CAGR during the forecast period (2023-2029).
The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.
Monoclonal antibodies (MABs) are a type of targeted drug therapy. These drugs recognise and find specific proteins on cancer cells. There are many different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing.
This report studies the global Therapeutic Monoclonal Antibodies Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Therapeutic Monoclonal Antibodies Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Monoclonal Antibodies Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Therapeutic Monoclonal Antibodies Drug total production and demand, 2018-2029, (Tons)
Global Therapeutic Monoclonal Antibodies Drug total production value, 2018-2029, (USD Million)
Global Therapeutic Monoclonal Antibodies Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Therapeutic Monoclonal Antibodies Drug domestic production, consumption, key domestic manufacturers and share
Global Therapeutic Monoclonal Antibodies Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global Therapeutic Monoclonal Antibodies Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca and Merck & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Monoclonal Antibodies Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Therapeutic Monoclonal Antibodies Drug Market, By Region:
1. How big is the global Therapeutic Monoclonal Antibodies Drug market?
2. What is the demand of the global Therapeutic Monoclonal Antibodies Drug market?
3. What is the year over year growth of the global Therapeutic Monoclonal Antibodies Drug market?
4. What is the production and production value of the global Therapeutic Monoclonal Antibodies Drug market?
5. Who are the key producers in the global Therapeutic Monoclonal Antibodies Drug market?
The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.
Monoclonal antibodies (MABs) are a type of targeted drug therapy. These drugs recognise and find specific proteins on cancer cells. There are many different MABs to treat cancer. They work in different ways to kill the cancer cell or stop it from growing.
This report studies the global Therapeutic Monoclonal Antibodies Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Therapeutic Monoclonal Antibodies Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Monoclonal Antibodies Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Therapeutic Monoclonal Antibodies Drug total production and demand, 2018-2029, (Tons)
Global Therapeutic Monoclonal Antibodies Drug total production value, 2018-2029, (USD Million)
Global Therapeutic Monoclonal Antibodies Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug consumption by region & country, CAGR, 2018-2029 & (Tons)
U.S. VS China: Therapeutic Monoclonal Antibodies Drug domestic production, consumption, key domestic manufacturers and share
Global Therapeutic Monoclonal Antibodies Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Tons)
Global Therapeutic Monoclonal Antibodies Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (Tons).
This reports profiles key players in the global Therapeutic Monoclonal Antibodies Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca and Merck & Co, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Monoclonal Antibodies Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Therapeutic Monoclonal Antibodies Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Mouse-derived Antibodies
- Chimeric Antibodies
- Humanized Antibodies
- Immune Diseases
- Cancer
- Other
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- Regeneron
- Innovent
- Hengrui Medicine
1. How big is the global Therapeutic Monoclonal Antibodies Drug market?
2. What is the demand of the global Therapeutic Monoclonal Antibodies Drug market?
3. What is the year over year growth of the global Therapeutic Monoclonal Antibodies Drug market?
4. What is the production and production value of the global Therapeutic Monoclonal Antibodies Drug market?
5. Who are the key producers in the global Therapeutic Monoclonal Antibodies Drug market?
1 SUPPLY SUMMARY
1.1 Therapeutic Monoclonal Antibodies Drug Introduction
1.2 World Therapeutic Monoclonal Antibodies Drug Supply & Forecast
1.2.1 World Therapeutic Monoclonal Antibodies Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.2.3 World Therapeutic Monoclonal Antibodies Drug Pricing Trends (2018-2029)
1.3 World Therapeutic Monoclonal Antibodies Drug Production by Region (Based on Production Site)
1.3.1 World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018-2029)
1.3.2 World Therapeutic Monoclonal Antibodies Drug Production by Region (2018-2029)
1.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2018-2029)
1.3.4 North America Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.5 Europe Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.6 China Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.7 Japan Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Monoclonal Antibodies Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Therapeutic Monoclonal Antibodies Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Therapeutic Monoclonal Antibodies Drug Demand (2018-2029)
2.2 World Therapeutic Monoclonal Antibodies Drug Consumption by Region
2.2.1 World Therapeutic Monoclonal Antibodies Drug Consumption by Region (2018-2023)
2.2.2 World Therapeutic Monoclonal Antibodies Drug Consumption Forecast by Region (2024-2029)
2.3 United States Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.4 China Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.5 Europe Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.6 Japan Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.7 South Korea Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.8 ASEAN Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.9 India Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
3 WORLD THERAPEUTIC MONOCLONAL ANTIBODIES DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Therapeutic Monoclonal Antibodies Drug Production Value by Manufacturer (2018-2023)
3.2 World Therapeutic Monoclonal Antibodies Drug Production by Manufacturer (2018-2023)
3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Manufacturer (2018-2023)
3.4 Therapeutic Monoclonal Antibodies Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Therapeutic Monoclonal Antibodies Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Therapeutic Monoclonal Antibodies Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Therapeutic Monoclonal Antibodies Drug in 2022
3.6 Therapeutic Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.6.1 Therapeutic Monoclonal Antibodies Drug Market: Region Footprint
3.6.2 Therapeutic Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.6.3 Therapeutic Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Comparison
4.1.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Comparison
4.2.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Comparison
4.3.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
4.5 China Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share
4.5.1 China Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
4.6 Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Therapeutic Monoclonal Antibodies Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Mouse-derived Antibodies
5.2.2 Chimeric Antibodies
5.2.3 Humanized Antibodies
5.3 Market Segment by Type
5.3.1 World Therapeutic Monoclonal Antibodies Drug Production by Type (2018-2029)
5.3.2 World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2018-2029)
5.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Therapeutic Monoclonal Antibodies Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immune Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Therapeutic Monoclonal Antibodies Drug Production by Application (2018-2029)
6.3.2 World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2018-2029)
6.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Therapeutic Monoclonal Antibodies Drug Product and Services
7.1.4 AbbVie Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Product and Services
7.2.4 Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Therapeutic Monoclonal Antibodies Drug Product and Services
7.3.4 Novartis Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Gilead Sciences
7.4.1 Gilead Sciences Details
7.4.2 Gilead Sciences Major Business
7.4.3 Gilead Sciences Therapeutic Monoclonal Antibodies Drug Product and Services
7.4.4 Gilead Sciences Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Gilead Sciences Recent Developments/Updates
7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
7.5 Roche
7.5.1 Roche Details
7.5.2 Roche Major Business
7.5.3 Roche Therapeutic Monoclonal Antibodies Drug Product and Services
7.5.4 Roche Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Roche Recent Developments/Updates
7.5.6 Roche Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Product and Services
7.6.4 Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen Therapeutic Monoclonal Antibodies Drug Product and Services
7.7.4 Amgen Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Therapeutic Monoclonal Antibodies Drug Product and Services
7.8.4 AstraZeneca Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Merck & Co
7.9.1 Merck & Co Details
7.9.2 Merck & Co Major Business
7.9.3 Merck & Co Therapeutic Monoclonal Antibodies Drug Product and Services
7.9.4 Merck & Co Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co Recent Developments/Updates
7.9.6 Merck & Co Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Therapeutic Monoclonal Antibodies Drug Product and Services
7.10.4 Takeda Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Therapeutic Monoclonal Antibodies Drug Product and Services
7.11.4 Merck KGaA Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 Seagen
7.12.1 Seagen Details
7.12.2 Seagen Major Business
7.12.3 Seagen Therapeutic Monoclonal Antibodies Drug Product and Services
7.12.4 Seagen Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Seagen Recent Developments/Updates
7.12.6 Seagen Competitive Strengths & Weaknesses
7.13 Eli Lilly
7.13.1 Eli Lilly Details
7.13.2 Eli Lilly Major Business
7.13.3 Eli Lilly Therapeutic Monoclonal Antibodies Drug Product and Services
7.13.4 Eli Lilly Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly Recent Developments/Updates
7.13.6 Eli Lilly Competitive Strengths & Weaknesses
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Details
7.14.2 Ono Pharmaceutical Major Business
7.14.3 Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Product and Services
7.14.4 Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ono Pharmaceutical Recent Developments/Updates
7.14.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.15 Pfizer
7.15.1 Pfizer Details
7.15.2 Pfizer Major Business
7.15.3 Pfizer Therapeutic Monoclonal Antibodies Drug Product and Services
7.15.4 Pfizer Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Pfizer Recent Developments/Updates
7.15.6 Pfizer Competitive Strengths & Weaknesses
7.16 Regeneron
7.16.1 Regeneron Details
7.16.2 Regeneron Major Business
7.16.3 Regeneron Therapeutic Monoclonal Antibodies Drug Product and Services
7.16.4 Regeneron Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Regeneron Recent Developments/Updates
7.16.6 Regeneron Competitive Strengths & Weaknesses
7.17 Innovent
7.17.1 Innovent Details
7.17.2 Innovent Major Business
7.17.3 Innovent Therapeutic Monoclonal Antibodies Drug Product and Services
7.17.4 Innovent Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Innovent Recent Developments/Updates
7.17.6 Innovent Competitive Strengths & Weaknesses
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Details
7.18.2 Hengrui Medicine Major Business
7.18.3 Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Product and Services
7.18.4 Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Hengrui Medicine Recent Developments/Updates
7.18.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Therapeutic Monoclonal Antibodies Drug Industry Chain
8.2 Therapeutic Monoclonal Antibodies Drug Upstream Analysis
8.2.1 Therapeutic Monoclonal Antibodies Drug Core Raw Materials
8.2.2 Main Manufacturers of Therapeutic Monoclonal Antibodies Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Therapeutic Monoclonal Antibodies Drug Production Mode
8.6 Therapeutic Monoclonal Antibodies Drug Procurement Model
8.7 Therapeutic Monoclonal Antibodies Drug Industry Sales Model and Sales Channels
8.7.1 Therapeutic Monoclonal Antibodies Drug Sales Model
8.7.2 Therapeutic Monoclonal Antibodies Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Therapeutic Monoclonal Antibodies Drug Introduction
1.2 World Therapeutic Monoclonal Antibodies Drug Supply & Forecast
1.2.1 World Therapeutic Monoclonal Antibodies Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.2.3 World Therapeutic Monoclonal Antibodies Drug Pricing Trends (2018-2029)
1.3 World Therapeutic Monoclonal Antibodies Drug Production by Region (Based on Production Site)
1.3.1 World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018-2029)
1.3.2 World Therapeutic Monoclonal Antibodies Drug Production by Region (2018-2029)
1.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2018-2029)
1.3.4 North America Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.5 Europe Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.6 China Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.3.7 Japan Therapeutic Monoclonal Antibodies Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Therapeutic Monoclonal Antibodies Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Therapeutic Monoclonal Antibodies Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Therapeutic Monoclonal Antibodies Drug Demand (2018-2029)
2.2 World Therapeutic Monoclonal Antibodies Drug Consumption by Region
2.2.1 World Therapeutic Monoclonal Antibodies Drug Consumption by Region (2018-2023)
2.2.2 World Therapeutic Monoclonal Antibodies Drug Consumption Forecast by Region (2024-2029)
2.3 United States Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.4 China Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.5 Europe Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.6 Japan Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.7 South Korea Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.8 ASEAN Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
2.9 India Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029)
3 WORLD THERAPEUTIC MONOCLONAL ANTIBODIES DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Therapeutic Monoclonal Antibodies Drug Production Value by Manufacturer (2018-2023)
3.2 World Therapeutic Monoclonal Antibodies Drug Production by Manufacturer (2018-2023)
3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Manufacturer (2018-2023)
3.4 Therapeutic Monoclonal Antibodies Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Therapeutic Monoclonal Antibodies Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Therapeutic Monoclonal Antibodies Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Therapeutic Monoclonal Antibodies Drug in 2022
3.6 Therapeutic Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.6.1 Therapeutic Monoclonal Antibodies Drug Market: Region Footprint
3.6.2 Therapeutic Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.6.3 Therapeutic Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Comparison
4.1.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Comparison
4.2.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Comparison
4.3.1 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
4.5 China Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share
4.5.1 China Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
4.6 Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Therapeutic Monoclonal Antibodies Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Mouse-derived Antibodies
5.2.2 Chimeric Antibodies
5.2.3 Humanized Antibodies
5.3 Market Segment by Type
5.3.1 World Therapeutic Monoclonal Antibodies Drug Production by Type (2018-2029)
5.3.2 World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2018-2029)
5.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Therapeutic Monoclonal Antibodies Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Immune Diseases
6.2.2 Cancer
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Therapeutic Monoclonal Antibodies Drug Production by Application (2018-2029)
6.3.2 World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2018-2029)
6.3.3 World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Details
7.1.2 AbbVie Major Business
7.1.3 AbbVie Therapeutic Monoclonal Antibodies Drug Product and Services
7.1.4 AbbVie Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AbbVie Recent Developments/Updates
7.1.6 AbbVie Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Details
7.2.2 Johnson & Johnson Major Business
7.2.3 Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Product and Services
7.2.4 Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Johnson & Johnson Recent Developments/Updates
7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis Therapeutic Monoclonal Antibodies Drug Product and Services
7.3.4 Novartis Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 Gilead Sciences
7.4.1 Gilead Sciences Details
7.4.2 Gilead Sciences Major Business
7.4.3 Gilead Sciences Therapeutic Monoclonal Antibodies Drug Product and Services
7.4.4 Gilead Sciences Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Gilead Sciences Recent Developments/Updates
7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
7.5 Roche
7.5.1 Roche Details
7.5.2 Roche Major Business
7.5.3 Roche Therapeutic Monoclonal Antibodies Drug Product and Services
7.5.4 Roche Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Roche Recent Developments/Updates
7.5.6 Roche Competitive Strengths & Weaknesses
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Details
7.6.2 Bristol-Myers Squibb Major Business
7.6.3 Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Product and Services
7.6.4 Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bristol-Myers Squibb Recent Developments/Updates
7.6.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.7 Amgen
7.7.1 Amgen Details
7.7.2 Amgen Major Business
7.7.3 Amgen Therapeutic Monoclonal Antibodies Drug Product and Services
7.7.4 Amgen Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Amgen Recent Developments/Updates
7.7.6 Amgen Competitive Strengths & Weaknesses
7.8 AstraZeneca
7.8.1 AstraZeneca Details
7.8.2 AstraZeneca Major Business
7.8.3 AstraZeneca Therapeutic Monoclonal Antibodies Drug Product and Services
7.8.4 AstraZeneca Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 AstraZeneca Recent Developments/Updates
7.8.6 AstraZeneca Competitive Strengths & Weaknesses
7.9 Merck & Co
7.9.1 Merck & Co Details
7.9.2 Merck & Co Major Business
7.9.3 Merck & Co Therapeutic Monoclonal Antibodies Drug Product and Services
7.9.4 Merck & Co Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Merck & Co Recent Developments/Updates
7.9.6 Merck & Co Competitive Strengths & Weaknesses
7.10 Takeda
7.10.1 Takeda Details
7.10.2 Takeda Major Business
7.10.3 Takeda Therapeutic Monoclonal Antibodies Drug Product and Services
7.10.4 Takeda Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Takeda Recent Developments/Updates
7.10.6 Takeda Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Therapeutic Monoclonal Antibodies Drug Product and Services
7.11.4 Merck KGaA Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 Seagen
7.12.1 Seagen Details
7.12.2 Seagen Major Business
7.12.3 Seagen Therapeutic Monoclonal Antibodies Drug Product and Services
7.12.4 Seagen Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Seagen Recent Developments/Updates
7.12.6 Seagen Competitive Strengths & Weaknesses
7.13 Eli Lilly
7.13.1 Eli Lilly Details
7.13.2 Eli Lilly Major Business
7.13.3 Eli Lilly Therapeutic Monoclonal Antibodies Drug Product and Services
7.13.4 Eli Lilly Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Eli Lilly Recent Developments/Updates
7.13.6 Eli Lilly Competitive Strengths & Weaknesses
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Details
7.14.2 Ono Pharmaceutical Major Business
7.14.3 Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Product and Services
7.14.4 Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ono Pharmaceutical Recent Developments/Updates
7.14.6 Ono Pharmaceutical Competitive Strengths & Weaknesses
7.15 Pfizer
7.15.1 Pfizer Details
7.15.2 Pfizer Major Business
7.15.3 Pfizer Therapeutic Monoclonal Antibodies Drug Product and Services
7.15.4 Pfizer Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Pfizer Recent Developments/Updates
7.15.6 Pfizer Competitive Strengths & Weaknesses
7.16 Regeneron
7.16.1 Regeneron Details
7.16.2 Regeneron Major Business
7.16.3 Regeneron Therapeutic Monoclonal Antibodies Drug Product and Services
7.16.4 Regeneron Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Regeneron Recent Developments/Updates
7.16.6 Regeneron Competitive Strengths & Weaknesses
7.17 Innovent
7.17.1 Innovent Details
7.17.2 Innovent Major Business
7.17.3 Innovent Therapeutic Monoclonal Antibodies Drug Product and Services
7.17.4 Innovent Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Innovent Recent Developments/Updates
7.17.6 Innovent Competitive Strengths & Weaknesses
7.18 Hengrui Medicine
7.18.1 Hengrui Medicine Details
7.18.2 Hengrui Medicine Major Business
7.18.3 Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Product and Services
7.18.4 Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Hengrui Medicine Recent Developments/Updates
7.18.6 Hengrui Medicine Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Therapeutic Monoclonal Antibodies Drug Industry Chain
8.2 Therapeutic Monoclonal Antibodies Drug Upstream Analysis
8.2.1 Therapeutic Monoclonal Antibodies Drug Core Raw Materials
8.2.2 Main Manufacturers of Therapeutic Monoclonal Antibodies Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Therapeutic Monoclonal Antibodies Drug Production Mode
8.6 Therapeutic Monoclonal Antibodies Drug Procurement Model
8.7 Therapeutic Monoclonal Antibodies Drug Industry Sales Model and Sales Channels
8.7.1 Therapeutic Monoclonal Antibodies Drug Sales Model
8.7.2 Therapeutic Monoclonal Antibodies Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2018-2023)
Table 5. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2024-2029)
Table 6. World Therapeutic Monoclonal Antibodies Drug Production by Region (2018-2023) & (Tons)
Table 7. World Therapeutic Monoclonal Antibodies Drug Production by Region (2024-2029) & (Tons)
Table 8. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2018-2023)
Table 9. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2024-2029)
Table 10. World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Therapeutic Monoclonal Antibodies Drug Major Market Trends
Table 13. World Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Therapeutic Monoclonal Antibodies Drug Consumption by Region (2018-2023) & (Tons)
Table 15. World Therapeutic Monoclonal Antibodies Drug Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Therapeutic Monoclonal Antibodies Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Therapeutic Monoclonal Antibodies Drug Producers in 2022
Table 18. World Therapeutic Monoclonal Antibodies Drug Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Therapeutic Monoclonal Antibodies Drug Producers in 2022
Table 20. World Therapeutic Monoclonal Antibodies Drug Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Therapeutic Monoclonal Antibodies Drug Company Evaluation Quadrant
Table 22. World Therapeutic Monoclonal Antibodies Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Therapeutic Monoclonal Antibodies Drug Production Site of Key Manufacturer
Table 24. Therapeutic Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 25. Therapeutic Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 26. Therapeutic Monoclonal Antibodies Drug Competitive Factors
Table 27. Therapeutic Monoclonal Antibodies Drug New Entrant and Capacity Expansion Plans
Table 28. Therapeutic Monoclonal Antibodies Drug Mergers & Acquisitions Activity
Table 29. United States VS China Therapeutic Monoclonal Antibodies Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Therapeutic Monoclonal Antibodies Drug Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Therapeutic Monoclonal Antibodies Drug Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 37. China Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 47. World Therapeutic Monoclonal Antibodies Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Therapeutic Monoclonal Antibodies Drug Production by Type (2018-2023) & (Tons)
Table 49. World Therapeutic Monoclonal Antibodies Drug Production by Type (2024-2029) & (Tons)
Table 50. World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Therapeutic Monoclonal Antibodies Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Therapeutic Monoclonal Antibodies Drug Production by Application (2018-2023) & (Tons)
Table 56. World Therapeutic Monoclonal Antibodies Drug Production by Application (2024-2029) & (Tons)
Table 57. World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2024-2029) & (US$/Ton)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Therapeutic Monoclonal Antibodies Drug Product and Services
Table 64. AbbVie Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Product and Services
Table 70. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Therapeutic Monoclonal Antibodies Drug Product and Services
Table 76. Novartis Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 80. Gilead Sciences Major Business
Table 81. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Product and Services
Table 82. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Gilead Sciences Recent Developments/Updates
Table 84. Gilead Sciences Competitive Strengths & Weaknesses
Table 85. Roche Basic Information, Manufacturing Base and Competitors
Table 86. Roche Major Business
Table 87. Roche Therapeutic Monoclonal Antibodies Drug Product and Services
Table 88. Roche Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Roche Recent Developments/Updates
Table 90. Roche Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Major Business
Table 93. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Product and Services
Table 94. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Recent Developments/Updates
Table 96. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 97. Amgen Basic Information, Manufacturing Base and Competitors
Table 98. Amgen Major Business
Table 99. Amgen Therapeutic Monoclonal Antibodies Drug Product and Services
Table 100. Amgen Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Amgen Recent Developments/Updates
Table 102. Amgen Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Therapeutic Monoclonal Antibodies Drug Product and Services
Table 106. AstraZeneca Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co Major Business
Table 111. Merck & Co Therapeutic Monoclonal Antibodies Drug Product and Services
Table 112. Merck & Co Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck & Co Recent Developments/Updates
Table 114. Merck & Co Competitive Strengths & Weaknesses
Table 115. Takeda Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Major Business
Table 117. Takeda Therapeutic Monoclonal Antibodies Drug Product and Services
Table 118. Takeda Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Takeda Recent Developments/Updates
Table 120. Takeda Competitive Strengths & Weaknesses
Table 121. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 122. Merck KGaA Major Business
Table 123. Merck KGaA Therapeutic Monoclonal Antibodies Drug Product and Services
Table 124. Merck KGaA Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck KGaA Recent Developments/Updates
Table 126. Merck KGaA Competitive Strengths & Weaknesses
Table 127. Seagen Basic Information, Manufacturing Base and Competitors
Table 128. Seagen Major Business
Table 129. Seagen Therapeutic Monoclonal Antibodies Drug Product and Services
Table 130. Seagen Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Seagen Recent Developments/Updates
Table 132. Seagen Competitive Strengths & Weaknesses
Table 133. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Eli Lilly Major Business
Table 135. Eli Lilly Therapeutic Monoclonal Antibodies Drug Product and Services
Table 136. Eli Lilly Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Eli Lilly Recent Developments/Updates
Table 138. Eli Lilly Competitive Strengths & Weaknesses
Table 139. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Ono Pharmaceutical Major Business
Table 141. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Product and Services
Table 142. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ono Pharmaceutical Recent Developments/Updates
Table 144. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Pfizer Basic Information, Manufacturing Base and Competitors
Table 146. Pfizer Major Business
Table 147. Pfizer Therapeutic Monoclonal Antibodies Drug Product and Services
Table 148. Pfizer Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Pfizer Recent Developments/Updates
Table 150. Pfizer Competitive Strengths & Weaknesses
Table 151. Regeneron Basic Information, Manufacturing Base and Competitors
Table 152. Regeneron Major Business
Table 153. Regeneron Therapeutic Monoclonal Antibodies Drug Product and Services
Table 154. Regeneron Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Regeneron Recent Developments/Updates
Table 156. Regeneron Competitive Strengths & Weaknesses
Table 157. Innovent Basic Information, Manufacturing Base and Competitors
Table 158. Innovent Major Business
Table 159. Innovent Therapeutic Monoclonal Antibodies Drug Product and Services
Table 160. Innovent Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Innovent Recent Developments/Updates
Table 162. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 163. Hengrui Medicine Major Business
Table 164. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Product and Services
Table 165. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Therapeutic Monoclonal Antibodies Drug Upstream (Raw Materials)
Table 167. Therapeutic Monoclonal Antibodies Drug Typical Customers
Table 168. Therapeutic Monoclonal Antibodies Drug Typical Distributors
LIST OF FIGURE
Figure 1. Therapeutic Monoclonal Antibodies Drug Picture
Figure 2. World Therapeutic Monoclonal Antibodies Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Therapeutic Monoclonal Antibodies Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 5. World Therapeutic Monoclonal Antibodies Drug Average Price (2018-2029) & (US$/Ton)
Figure 6. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2018-2029)
Figure 8. North America Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 9. Europe Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 10. China Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 11. Japan Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 12. Therapeutic Monoclonal Antibodies Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 15. World Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 17. China Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 18. Europe Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 19. Japan Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 20. South Korea Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 22. India Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Therapeutic Monoclonal Antibodies Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Therapeutic Monoclonal Antibodies Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Therapeutic Monoclonal Antibodies Drug Markets in 2022
Figure 26. United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Therapeutic Monoclonal Antibodies Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 30. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 32. World Therapeutic Monoclonal Antibodies Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type in 2022
Figure 34. Mouse-derived Antibodies
Figure 35. Chimeric Antibodies
Figure 36. Humanized Antibodies
Figure 37. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Type (2018-2029)
Figure 38. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World Therapeutic Monoclonal Antibodies Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application in 2022
Figure 42. Immune Diseases
Figure 43. Cancer
Figure 44. Other
Figure 45. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Application (2018-2029)
Figure 46. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application (2018-2029)
Figure 47. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. Therapeutic Monoclonal Antibodies Drug Industry Chain
Figure 49. Therapeutic Monoclonal Antibodies Drug Procurement Model
Figure 50. Therapeutic Monoclonal Antibodies Drug Sales Model
Figure 51. Therapeutic Monoclonal Antibodies Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Therapeutic Monoclonal Antibodies Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2018-2023)
Table 5. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2024-2029)
Table 6. World Therapeutic Monoclonal Antibodies Drug Production by Region (2018-2023) & (Tons)
Table 7. World Therapeutic Monoclonal Antibodies Drug Production by Region (2024-2029) & (Tons)
Table 8. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2018-2023)
Table 9. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2024-2029)
Table 10. World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2018-2023) & (US$/Ton)
Table 11. World Therapeutic Monoclonal Antibodies Drug Average Price by Region (2024-2029) & (US$/Ton)
Table 12. Therapeutic Monoclonal Antibodies Drug Major Market Trends
Table 13. World Therapeutic Monoclonal Antibodies Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Tons)
Table 14. World Therapeutic Monoclonal Antibodies Drug Consumption by Region (2018-2023) & (Tons)
Table 15. World Therapeutic Monoclonal Antibodies Drug Consumption Forecast by Region (2024-2029) & (Tons)
Table 16. World Therapeutic Monoclonal Antibodies Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Therapeutic Monoclonal Antibodies Drug Producers in 2022
Table 18. World Therapeutic Monoclonal Antibodies Drug Production by Manufacturer (2018-2023) & (Tons)
Table 19. Production Market Share of Key Therapeutic Monoclonal Antibodies Drug Producers in 2022
Table 20. World Therapeutic Monoclonal Antibodies Drug Average Price by Manufacturer (2018-2023) & (US$/Ton)
Table 21. Global Therapeutic Monoclonal Antibodies Drug Company Evaluation Quadrant
Table 22. World Therapeutic Monoclonal Antibodies Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Therapeutic Monoclonal Antibodies Drug Production Site of Key Manufacturer
Table 24. Therapeutic Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 25. Therapeutic Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 26. Therapeutic Monoclonal Antibodies Drug Competitive Factors
Table 27. Therapeutic Monoclonal Antibodies Drug New Entrant and Capacity Expansion Plans
Table 28. Therapeutic Monoclonal Antibodies Drug Mergers & Acquisitions Activity
Table 29. United States VS China Therapeutic Monoclonal Antibodies Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Therapeutic Monoclonal Antibodies Drug Production Comparison, (2018 & 2022 & 2029) & (Tons)
Table 31. United States VS China Therapeutic Monoclonal Antibodies Drug Consumption Comparison, (2018 & 2022 & 2029) & (Tons)
Table 32. United States Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 36. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 37. China Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 41. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Therapeutic Monoclonal Antibodies Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production (2018-2023) & (Tons)
Table 46. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share (2018-2023)
Table 47. World Therapeutic Monoclonal Antibodies Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Therapeutic Monoclonal Antibodies Drug Production by Type (2018-2023) & (Tons)
Table 49. World Therapeutic Monoclonal Antibodies Drug Production by Type (2024-2029) & (Tons)
Table 50. World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Therapeutic Monoclonal Antibodies Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2023) & (US$/Ton)
Table 53. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2024-2029) & (US$/Ton)
Table 54. World Therapeutic Monoclonal Antibodies Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Therapeutic Monoclonal Antibodies Drug Production by Application (2018-2023) & (Tons)
Table 56. World Therapeutic Monoclonal Antibodies Drug Production by Application (2024-2029) & (Tons)
Table 57. World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Therapeutic Monoclonal Antibodies Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2023) & (US$/Ton)
Table 60. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2024-2029) & (US$/Ton)
Table 61. AbbVie Basic Information, Manufacturing Base and Competitors
Table 62. AbbVie Major Business
Table 63. AbbVie Therapeutic Monoclonal Antibodies Drug Product and Services
Table 64. AbbVie Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AbbVie Recent Developments/Updates
Table 66. AbbVie Competitive Strengths & Weaknesses
Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 68. Johnson & Johnson Major Business
Table 69. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Product and Services
Table 70. Johnson & Johnson Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Johnson & Johnson Recent Developments/Updates
Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis Therapeutic Monoclonal Antibodies Drug Product and Services
Table 76. Novartis Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 80. Gilead Sciences Major Business
Table 81. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Product and Services
Table 82. Gilead Sciences Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Gilead Sciences Recent Developments/Updates
Table 84. Gilead Sciences Competitive Strengths & Weaknesses
Table 85. Roche Basic Information, Manufacturing Base and Competitors
Table 86. Roche Major Business
Table 87. Roche Therapeutic Monoclonal Antibodies Drug Product and Services
Table 88. Roche Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Roche Recent Developments/Updates
Table 90. Roche Competitive Strengths & Weaknesses
Table 91. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 92. Bristol-Myers Squibb Major Business
Table 93. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Product and Services
Table 94. Bristol-Myers Squibb Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bristol-Myers Squibb Recent Developments/Updates
Table 96. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 97. Amgen Basic Information, Manufacturing Base and Competitors
Table 98. Amgen Major Business
Table 99. Amgen Therapeutic Monoclonal Antibodies Drug Product and Services
Table 100. Amgen Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Amgen Recent Developments/Updates
Table 102. Amgen Competitive Strengths & Weaknesses
Table 103. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 104. AstraZeneca Major Business
Table 105. AstraZeneca Therapeutic Monoclonal Antibodies Drug Product and Services
Table 106. AstraZeneca Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. AstraZeneca Recent Developments/Updates
Table 108. AstraZeneca Competitive Strengths & Weaknesses
Table 109. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 110. Merck & Co Major Business
Table 111. Merck & Co Therapeutic Monoclonal Antibodies Drug Product and Services
Table 112. Merck & Co Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Merck & Co Recent Developments/Updates
Table 114. Merck & Co Competitive Strengths & Weaknesses
Table 115. Takeda Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Major Business
Table 117. Takeda Therapeutic Monoclonal Antibodies Drug Product and Services
Table 118. Takeda Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Takeda Recent Developments/Updates
Table 120. Takeda Competitive Strengths & Weaknesses
Table 121. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 122. Merck KGaA Major Business
Table 123. Merck KGaA Therapeutic Monoclonal Antibodies Drug Product and Services
Table 124. Merck KGaA Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Merck KGaA Recent Developments/Updates
Table 126. Merck KGaA Competitive Strengths & Weaknesses
Table 127. Seagen Basic Information, Manufacturing Base and Competitors
Table 128. Seagen Major Business
Table 129. Seagen Therapeutic Monoclonal Antibodies Drug Product and Services
Table 130. Seagen Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Seagen Recent Developments/Updates
Table 132. Seagen Competitive Strengths & Weaknesses
Table 133. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 134. Eli Lilly Major Business
Table 135. Eli Lilly Therapeutic Monoclonal Antibodies Drug Product and Services
Table 136. Eli Lilly Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Eli Lilly Recent Developments/Updates
Table 138. Eli Lilly Competitive Strengths & Weaknesses
Table 139. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Ono Pharmaceutical Major Business
Table 141. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Product and Services
Table 142. Ono Pharmaceutical Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ono Pharmaceutical Recent Developments/Updates
Table 144. Ono Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Pfizer Basic Information, Manufacturing Base and Competitors
Table 146. Pfizer Major Business
Table 147. Pfizer Therapeutic Monoclonal Antibodies Drug Product and Services
Table 148. Pfizer Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Pfizer Recent Developments/Updates
Table 150. Pfizer Competitive Strengths & Weaknesses
Table 151. Regeneron Basic Information, Manufacturing Base and Competitors
Table 152. Regeneron Major Business
Table 153. Regeneron Therapeutic Monoclonal Antibodies Drug Product and Services
Table 154. Regeneron Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Regeneron Recent Developments/Updates
Table 156. Regeneron Competitive Strengths & Weaknesses
Table 157. Innovent Basic Information, Manufacturing Base and Competitors
Table 158. Innovent Major Business
Table 159. Innovent Therapeutic Monoclonal Antibodies Drug Product and Services
Table 160. Innovent Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Innovent Recent Developments/Updates
Table 162. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 163. Hengrui Medicine Major Business
Table 164. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Product and Services
Table 165. Hengrui Medicine Therapeutic Monoclonal Antibodies Drug Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 166. Global Key Players of Therapeutic Monoclonal Antibodies Drug Upstream (Raw Materials)
Table 167. Therapeutic Monoclonal Antibodies Drug Typical Customers
Table 168. Therapeutic Monoclonal Antibodies Drug Typical Distributors
LIST OF FIGURE
Figure 1. Therapeutic Monoclonal Antibodies Drug Picture
Figure 2. World Therapeutic Monoclonal Antibodies Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Therapeutic Monoclonal Antibodies Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 5. World Therapeutic Monoclonal Antibodies Drug Average Price (2018-2029) & (US$/Ton)
Figure 6. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Region (2018-2029)
Figure 8. North America Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 9. Europe Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 10. China Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 11. Japan Therapeutic Monoclonal Antibodies Drug Production (2018-2029) & (Tons)
Figure 12. Therapeutic Monoclonal Antibodies Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 15. World Therapeutic Monoclonal Antibodies Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 17. China Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 18. Europe Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 19. Japan Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 20. South Korea Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 21. ASEAN Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 22. India Therapeutic Monoclonal Antibodies Drug Consumption (2018-2029) & (Tons)
Figure 23. Producer Shipments of Therapeutic Monoclonal Antibodies Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Therapeutic Monoclonal Antibodies Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Therapeutic Monoclonal Antibodies Drug Markets in 2022
Figure 26. United States VS China: Therapeutic Monoclonal Antibodies Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Therapeutic Monoclonal Antibodies Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Therapeutic Monoclonal Antibodies Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 30. China Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Therapeutic Monoclonal Antibodies Drug Production Market Share 2022
Figure 32. World Therapeutic Monoclonal Antibodies Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type in 2022
Figure 34. Mouse-derived Antibodies
Figure 35. Chimeric Antibodies
Figure 36. Humanized Antibodies
Figure 37. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Type (2018-2029)
Figure 38. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Therapeutic Monoclonal Antibodies Drug Average Price by Type (2018-2029) & (US$/Ton)
Figure 40. World Therapeutic Monoclonal Antibodies Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application in 2022
Figure 42. Immune Diseases
Figure 43. Cancer
Figure 44. Other
Figure 45. World Therapeutic Monoclonal Antibodies Drug Production Market Share by Application (2018-2029)
Figure 46. World Therapeutic Monoclonal Antibodies Drug Production Value Market Share by Application (2018-2029)
Figure 47. World Therapeutic Monoclonal Antibodies Drug Average Price by Application (2018-2029) & (US$/Ton)
Figure 48. Therapeutic Monoclonal Antibodies Drug Industry Chain
Figure 49. Therapeutic Monoclonal Antibodies Drug Procurement Model
Figure 50. Therapeutic Monoclonal Antibodies Drug Sales Model
Figure 51. Therapeutic Monoclonal Antibodies Drug Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
